A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy

BACKGROUND: At present, there is insufficient medical evidence to determine whether adjuvant chemotherapy is necessary for T2N0M0 gastric cancer. AIM: To obtain a risk score to assess the need for adjuvant chemotherapy in patients with T2N0M0 gastric cancer. METHODS: We identified 325 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Quan, Kang, Wen-Zhe, Xiong, Jian-Ping, Shao, Xin-Xin, Li, Wei-Kun, Hu, Hai-Tao, Tian, Yan-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594010/
https://www.ncbi.nlm.nih.gov/pubmed/36304088
http://dx.doi.org/10.3748/wjg.v28.i38.5626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594010/
https://www.ncbi.nlm.nih.gov/pubmed/36304088
http://dx.doi.org/10.3748/wjg.v28.i38.5626

Ejemplares similares